Baidu
map

内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2023 NICE 高度专业化的技术指南：Asfotase alfa 用于治疗小儿发病的低磷酸酯酶症【HST23】

2023-03-01 英国国家卫生与临床优化研究所 NICE官网 发表于安徽省

低磷酸酯酶症Asfotase alfa

关于 asfotase alfa (Strensiq) 治疗婴儿、儿童、年轻人和成人的儿科发作性低磷酸酯酶症的循证建议。

中文标题：

2023 NICE 高度专业化的技术指南：Asfotase alfa 用于治疗小儿发病的低磷酸酯酶症【HST23】

英文标题：

Asfotase alfa for treating paediatric-onset hypophosphatasia

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2023-03-01

简要介绍：

关于 asfotase alfa (Strensiq) 治疗婴儿、儿童、年轻人和成人的儿科发作性低磷酸酯酶症的循证建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2023 NICE 高度专业化的技术指南：【HST23】.pdf)] GetToolGuiderByIdResponse(projectId=1, id=778b31c003009395, title=2023 NICE 高度专业化的技术指南：Asfotase alfa 用于治疗小儿发病的低磷酸酯酶症【HST23】, enTitle=Asfotase alfa for treating paediatric-onset hypophosphatasia , guiderFrom=NICE官网, authorId=0, author=, summary=关于 asfotase alfa (Strensiq) 治疗婴儿、儿童、年轻人和成人的儿科发作性低磷酸酯酶症的循证建议。, cover=https://img.medsci.cn/Random/confident-experienced-doctor-NJVKHS4.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Wed Mar 01 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p><span style="color: #000000;">关于 asfotase alfa (Strensiq) 治疗婴儿、儿童、年轻人和成人的儿科发作性低磷酸酯酶症的循证建议。</span></p>, tagList=[TagDto(tagId=445611, tagName=低磷酸酯酶症), TagDto(tagId=472361, tagName=Asfotase alfa)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=445611, articleKeyword=低磷酸酯酶症, articleKeywordNum=6, guiderKeywordId=445611, guiderKeyword=低磷酸酯酶症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2844, appHits=23, showAppHits=0, pcHits=230, showPcHits=2818, likes=0, shares=6, comments=2, approvalStatus=1, publishedTime=Sun Mar 05 09:55:00 CST 2023, publishedTimeString=2023-03-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Mar 01 09:57:11 CST 2023, updatedBy=2427819, updatedName=梁丽玲, updatedTime=Thu Jan 04 04:00:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=安徽省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 NICE 高度专业化的技术指南：【HST23】.pdf)])
2023 NICE 高度专业化的技术指南：【HST23】.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2117704, encodeId=65c4211e7048f, content=<a href='/topic/show?id=c52a105412b0' target=_blank style='color:#2F92EE;'>#Asfotase alfa#</a> 用于治疗小儿发病的<a href='/topic/show?id=a4c5105413d5' target=_blank style='color:#2F92EE;'>#低***酶症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=105412, encryptionId=c52a105412b0, topicName=Asfotase alfa), TopicDto(id=105413, encryptionId=a4c5105413d5, topicName=低***酶症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Mar 05 10:45:41 CST 2023, time=2023-03-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117703, encodeId=f67c211e70329, content=<a href='/topic/show?id=c52a105412b0' target=_blank style='color:#2F92EE;'>#Asfotase alfa#</a> 用于治疗小儿发病的<a href='/topic/show?id=a4c5105413d5' target=_blank style='color:#2F92EE;'>#低***酶症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=105412, encryptionId=c52a105412b0, topicName=Asfotase alfa), TopicDto(id=105413, encryptionId=a4c5105413d5, topicName=低***酶症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Mar 05 10:44:32 CST 2023, time=2023-03-05, status=1, ipAttribution=上海)]
    2023-03-05 lifestar 来自上海

    #Asfotase alfa# 用于治疗小儿发病的#低***酶症#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2117704, encodeId=65c4211e7048f, content=<a href='/topic/show?id=c52a105412b0' target=_blank style='color:#2F92EE;'>#Asfotase alfa#</a> 用于治疗小儿发病的<a href='/topic/show?id=a4c5105413d5' target=_blank style='color:#2F92EE;'>#低***酶症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=105412, encryptionId=c52a105412b0, topicName=Asfotase alfa), TopicDto(id=105413, encryptionId=a4c5105413d5, topicName=低***酶症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Mar 05 10:45:41 CST 2023, time=2023-03-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117703, encodeId=f67c211e70329, content=<a href='/topic/show?id=c52a105412b0' target=_blank style='color:#2F92EE;'>#Asfotase alfa#</a> 用于治疗小儿发病的<a href='/topic/show?id=a4c5105413d5' target=_blank style='color:#2F92EE;'>#低***酶症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=105412, encryptionId=c52a105412b0, topicName=Asfotase alfa), TopicDto(id=105413, encryptionId=a4c5105413d5, topicName=低***酶症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Mar 05 10:44:32 CST 2023, time=2023-03-05, status=1, ipAttribution=上海)]
    2023-03-05 lifestar 来自上海

    #Asfotase alfa# 用于治疗小儿发病的#低***酶症#

    0

拓展阅读

“港澳药械通”先行政策：低磷酸酯酶症药Strensiq引入大湾区，罕见病新药可及性再提高

此次阿司福酶α注射液在大湾区的率先获批，是国内低磷酸酯酶症治疗的重大突破，为国内患有遗传性低磷酸酯酶症的儿童患者带来了新的治疗希望。

哥伦比亚共识：低磷酸酯酶症患者的诊断、治疗和随访

暂未更新 · 2024-12-12

Baidu
map
Baidu
map
Baidu
map